Bangert M, Altenmuller EO Mapping perception to action in piano practice: a longitudinal DC-EEG study. BMC Neurosci. 2003 Oct 15;4:26. doi: 10.1186/1471-2202-4-26.
Chiaravalloti ND, Moore NB, DeLuca J The efficacy of the modified Story Memory Technique in progressive MS. Mult Scler. 2020 Mar;26(3):354-362. doi: 10.1177/1352458519826463. Epub 2019 Feb 11.
Crowe SF The differential contribution of mental tracking, cognitive flexibility, visual search, and motor speed to performance on parts A and B of the Trail Making Test. J Clin Psychol. 1998 Aug;54(5):585-91. doi: 10.1002/(sici)1097-4679(199808)54:53.0.
D'Souza E Modified Fatigue Impact Scale - 5-item version (MFIS-5). Occup Med (Lond). 2016 Apr;66(3):256-7. doi: 10.1093/occmed/kqv106. No abstract available.
Gatz M, Prescott CA, Pedersen NL Lifestyle risk and delaying factors. Alzheimer Dis Assoc Disord. 2006 Jul-Sep;20(3 Suppl 2):S84-8. doi: 10.1097/00002093-200607001-00013.
Goldman Consensus Group The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler. 2005 Jun;11(3):328-37. doi: 10.1191/1352458505ms1162oa.
He D, Zhang Y, Dong S, Wang D, Gao X, Zhou H Pharmacological treatment for memory disorder in multiple sclerosis. Cochrane Database Syst Rev. 2013 Dec 17;(12):CD008876. doi: 10.1002/14651858.CD008876.pub3.
Heaton RK, Nelson LM, Thompson DS, Burks JS, Franklin GM Neuropsychological findings in relapsing-remitting and chronic-progressive multiple sclerosis. J Consult Clin Psychol. 1985 Feb;53(1):103-10. doi: 10.1037//0022-006x.53.1.103. No abstract available
Herholz SC, Zatorre RJ Musical training as a framework for brain plasticity: behavior, function, and structure. Neuron. 2012 Nov 8;76(3):486-502. doi: 10.1016/j.neuron.2012.10.011.
Mani A, Chohedri E, Ravanfar P, Mowla A, Nikseresht A Efficacy of group cognitive rehabilitation therapy in multiple sclerosis. Acta Neurol Scand. 2018 Jun;137(6):589-597. doi: 10.1111/ane.12904. Epub 2018 Feb 7.
Moreno S, Marques C, Santos A, Santos M, Castro SL, Besson M Musical training influences linguistic abilities in 8-year-old children: more evidence for brain plasticity. Cereb Cortex. 2009 Mar;19(3):712-23. doi: 10.1093/cercor/bhn120. Epub 2008 Oct 1.
Nunnari D, De Cola MC, Costa A, Rifici C, Bramanti P, Marino S Exploring cognitive reserve in multiple sclerosis: New findings from a cross-sectional study. J Clin Exp Neuropsychol. 2016 Dec;38(10):1158-67. doi: 10.1080/13803395.2016.1200538. Epub 2016 J
Rao SM, Leo GJ, Bernardin L, Unverzagt F Cognitive dysfunction in multiple sclerosis. I. Frequency, patterns, and prediction. Neurology. 1991 May;41(5):685-91. doi: 10.1212/wnl.41.5.685.
Rosti-Otajarvi EM, Hamalainen PI Neuropsychological rehabilitation for multiple sclerosis. Cochrane Database Syst Rev. 2014 Feb 11;(2):CD009131. doi: 10.1002/14651858.CD009131.pub3.
Scarmeas N, Levy G, Tang MX, Manly J, Stern Y Influence of leisure activity on the incidence of Alzheimer's disease. Neurology. 2001 Dec 26;57(12):2236-42. doi: 10.1212/wnl.57.12.2236.
Stanovich KE, Cunningham AE Studying the consequences of literacy within a literate society: the cognitive correlates of print exposure. Mem Cognit. 1992 Jan;20(1):51-68. doi: 10.3758/bf03208254.
Sumowski JF, Chiaravalloti N, Wylie G, Deluca J Cognitive reserve moderates the negative effect of brain atrophy on cognitive efficiency in multiple sclerosis. J Int Neuropsychol Soc. 2009 Jul;15(4):606-12. doi: 10.1017/S1355617709090912.
Sumowski JF, Leavitt VM Cognitive reserve in multiple sclerosis. Mult Scler. 2013 Aug;19(9):1122-7. doi: 10.1177/1352458513498834.
Sumowski JF Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis. Front Neurol. 2015 Aug 20;6:176. doi: 10.3389/fneur.2015.00176. eCollection 2015. No abstract available.
Wan CY, Schlaug G Music making as a tool for promoting brain plasticity across the life span. Neuroscientist. 2010 Oct;16(5):566-77. doi: 10.1177/1073858410377805.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.